Recent Publications by CFE Educators

Published Articles, Books and other Scholarships of the CFE

Recent Published articles, books, and other scholarship by Academy members, CFE Education Scientists, and CFE Faculty.

Volume 184 of Issue 6 | JAMA internal medicine 

Stigmatizing Language, Patient Demographics, and Errors in the Diagnostic Process.

 

2024

 

Authors: Brooks KC, Raffel KE, Chia D, Karwa A, Hubbard CC, Auerbach AD, Ranji SR

Journal of Clinical Oncology 

Optimizing hematology/oncology (H/O) curricula for internal medicine (IM) residents: A two-institution Delphi survey.

 

2024

 

Authors: Jordyn Silverstein, Laura Ann Huppert, Matthew Schwede, Sarah Goglin, Tyler Paul Johnson, Jennifer Babik, Sam Brondfield

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 

The shifting paradigm of gastrointestinal disease associated with antibody deficiencies.

 

2024

 

Authors: Monahan R, Otani IM

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting 

Launching an International Community of Practice in Hematology/Oncology Medical Education.

 

2024

 

Authors: Walsh K, Manochakian R, Schwartz J, Brondfield S

Health affairs (Project Hope) 

Prescription Digital Therapeutics: The Authors Reply.

 

2024

 

Authors: Kumar A, Redberg RF, Dhruva SS, Ross JS

Volume 81 of Issue 5 | Medical care research and review : MCRR 

Strengthening Primary Care Workforce Capacity in Dementia Diagnosis and Care: A Qualitative Study of Project Alzheimer's Disease-ECHO.

 

2024

 

Authors: Sideman AB, Hernandez de Jesus A, Alagappan C, Ma M, Koenig CJ, Alving LI, Segal-Gidan F, Goldberger R, Sohmer D, Rosen H

Journal of surgical education 

Comparing Peer and Faculty Feedback for Asynchronous Laparoscopic Skill Acquisition.

 

2024

 

Authors: Brian R, Cowan B, Knox JA, O'Sullivan PS, Bayne D, Ito T, Lager J, Chern H

Journal of Clinical Oncology 

I-SPY2 Endocrine Optimization Pilot (EOP): Neoadjuvant amcenestrant +/- abemaciclib +/- letrozole in molecularly selected patients (pts) with HR+ HER2- stage 2/3 breast cancer (BC).

 

2024

 

Authors: Amy Jo Chien, Rita A. Mukhtar, Karthik Giridhar, Olufunmilayo I. Olopade, Kevin Kalinsky, Christos Vaklavas, Anthony D. Elias, Mei Wei, Matthew P. Goetz, Laura van 't Veer, Silver Alkhafaji, Hope S. Rugo, Nan Chen, W. Fraser Fraser Symmans, Alexander D. Borowsky, Lamorna Brown Swigart, Natsuko Onishi, Douglas Yee, Nola Hylton, Laura Esserman